41
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Concomitant Prostate Needle Biopsy and Laser Vaporization of the Prostate Could Be a Risk of Postoperative Hemoglobin Decline, a Retrospective Study

ORCID Icon, , , &
Pages 123-129 | Received 31 Dec 2023, Accepted 18 May 2024, Published online: 03 Jun 2024

References

  • Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline Part II-surgical evaluation and treatment. J Urol. 2021;206(4):818–826. doi:10.1097/JU.0000000000002184
  • Okada T, Koura M, Sumikawa R, et al. A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia. Low Urin Tract Symptoms. 2022;14(5):373–379. doi:10.1111/luts.12453
  • Shake H, Alokda A, Mahmoud H. The Twister laser fiber degradation and tissue ablation capability during 980-nm high-power diode laser ablation of the prostate. A randomized study versus the standard side-firing fiber. Lasers Med Sci. 2012;27(5):959–963. doi:10.1007/s10103-011-1017-8
  • Wendt-Nordahl G, Huckele S, Honeck P, et al. 980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol. 2007;52(6):1723–1728. doi:10.1016/j.eururo.2007.06.029
  • Mithani MH, Khalid SE, Khan SA, et al. Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: a prospective study. Investig Clin Urol. 2018;59(6):392–398. doi:10.4111/icu.2018.59.6.392
  • Sanjo T, Tanaka N, Shinojima T, et al. Endoscopic vaporization of benign prostatic hyperplasia using a contact 980 nm diode laser under antithrombotic therapy: a prospective survey. Asian J Endosc Surg. 2022;15(3):585–590. doi:10.1111/ases.13057
  • Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer. Lyon, France. 2022; Available from: https://gco.iarc.who.int/today. Accessed May 21, 2024.
  • Abrams P, Chapple C, Khoury S, Roehrborn C, De la Rosette J. International scientific committee and members of the committees, 6th international consultation on new developments in prostate cancer and prostate diseases. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009;181(4):1779–1787. doi:10.1016/j.juro.2008.11.127
  • Mohler JL, Antonarakis ES, Armstrong AJ, et al. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(5):479–505.
  • Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol. 1994;151(5):1283–1290. doi:10.1016/S0022-5347(17)35233-3
  • Rietbergen JB, Kruger AE, Kranse R, Schröder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology. 1997;49(6):875–880. doi:10.1016/S0090-4295(97)00100-3
  • Turgut H, Sarıer M, Öztorun K, Yalçın K, Özgür GK. Evaluation of sexual function according to the size of the needle used in transrectal-ultrasonography-guided prostate biopsy. Bull Urooncol. 2021;20(3):138–141. doi:10.4274/uob.galenos.2020.1792
  • Ahmed HU, El-Shater Bosaily A, Brown LC, et al. PROMIS study group. diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–822. doi:10.1016/S0140-6736(16)32401-1
  • Yilmaz M, Toprak T, Suarez-Ibarrola R, et al. Incidental prostate cancer after holmium laser enucleation of the prostate-A narrative review. Andrologia. 2022;54(3):e14332. doi:10.1111/and.14332
  • Voigt S, Hüttig F, Koch R, et al. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia? Prostate. 2011;71(12):1325–1331. doi:10.1002/pros.21349
  • Vela-Navarrete R, Gonzalez‐Enguita C, Garcia‐Cardoso JV, Manzarbeitia F, Sarasa‐Corral JL, Granizo JJ. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). BJU Int. 2005;96(7):1045–1048. doi:10.1111/j.1464-410X.2005.05735.x
  • Bauersachs RM, Herold J. Oral anticoagulation in the elderly and frail. Hamostaseologie. 2020;40(01):74–83. doi:10.1055/s-0040-1701476
  • Chen YT, Chiang PH, Hsu CC. Simultaneous transurethral resection of prostate and prostate needle biopsy in patients with acute urinary retention and elevated prostate specific antigen levels. Chang Gung Med J. 2009;32(4):417–422.
  • Yang TY, Chow YC, Lin WR, et al. Concomitant transrectal ultrasound-guided biopsy and transurethral resection of prostate in patients with urinary retention and elevated serum prostate-specific antigen levels. J Chin Med Assoc. 2016;79(11):605–608. doi:10.1016/j.jcma.2016.03.008
  • Xiang J, Yan H, Li J, Wang X, Chen H, Zheng X. Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):31. doi:10.1186/s12957-019-1573-0
  • Tamada T, Sone T, Jo Y, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology. 2008;248(2):531–539. doi:10.1148/radiol.2482070157
  • Katta N, Santos D, Austin BM, et al. Laser coagulation and hemostasis of large diameter blood vessels: effect of shear stress and flow velocity. Sci Rep. 2022;12(1):8375. doi:10.1038/s41598-022-12128-1
  • Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246–249. doi:10.1016/j.juro.2008.03.058